4//SEC Filing
Stonehouse Jon P 4
Accession 0001127602-24-015365
CIK 0000882796other
Filed
May 14, 8:00 PM ET
Accepted
May 15, 7:08 AM ET
Size
6.3 KB
Accession
0001127602-24-015365
Insider Transaction Report
Form 4
Stonehouse Jon P
DirectorPresident & CEO
Transactions
- Purchase
Common Stock
2024-05-13$5.55/sh+30,000$166,500→ 1,127,770 total
Holdings
- 20,000(indirect: By Trust)
Common Stock
- 20,000(indirect: By Trust)
Common Stock
Footnotes (1)
- [F1]The price in column 4 is a weighted average price. These shares were purchased in multiple transactions ranging from $5.34 to $5.68. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares purchased at each price within the range set forth in this footnote.
Documents
Issuer
BIOCRYST PHARMACEUTICALS INC
CIK 0000882796
Entity typeother
Related Parties
1- filerCIK 0001385496
Filing Metadata
- Form type
- 4
- Filed
- May 14, 8:00 PM ET
- Accepted
- May 15, 7:08 AM ET
- Size
- 6.3 KB